When Alexa talks to patients with type 2 diabetes, apparently they listen. A study in JAMA Network Open found patients gained better glycemic control when they engaged with an artificial intelligence (AI) voice app—which was customized by their respective clinicians to help them achieve optimal insulin dosing. App users demonstrated significantly better insulin adherence and glycemic improvement during the 2-month trial. Glycemic control was measured by mean fasting blood glucose, rather than HbA1c. The app …
Read More